Company Overview and News
GEORGETOWN, Sept 24 (Reuters) - Guyana has put planned oil auctions on hold as the impoverished South American country works to establish a Department of Energy to oversee the energy boom, Minister of State Joseph Harmon said on Monday.
FP HES XOM CVX CEO
CNOOC Limited (CEO - Free Report) recently sold its Yuedong liquefied natural gas (LNG) terminal access to the state-owned Zhenhua Oil and private logistics firm, Longkou Shengtong Energy. The move, which facilitates China to liberalize its huge energy market, came forth as a result of an auction on the Shanghai Petroleum and Gas Exchange.
TCP KBH RGCO CEO
CNOOC Limited (CEO - Free Report) recently announced that the company has started production at its Penglai 19-3 oilfield 1/3/8/9 comprehensive adjustment project, one of the biggest offshore oilfields in China. The project is located 80 kilometers southeast from Penglai city and 216 kilometers northwest from Tanggu, in the south central part of Bohai Sea.
COP RGCO CEO
CNOOC Limited announced Tuesday that the Penglai 19-3 oilfield 1/3/8/9 comprehensive adjustment project has commenced production.
* China’s CNOOC Ltd started producing crude oil at 1/3/8/9 block of the Penglai 19-3 oilfield off north China’s Bohai Bay, the company said in a statement on Tuesday
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K
HONG KONG, Sept. 18, 2018 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883, NYSE: CEO, TSX: CNU) announced today the Penglai 19-3 oilfield 1/3/8/9 comprehensive adjustment project has commenced production.
China told the World Trade Organization (WTO) on Tuesday it wanted to impose $7 billion a year in sanctions on the United States in retaliation for Washington's non-compliance with a ruling in a dispute over US dumping duties. - AFP
CRBJY SBMFF SBHMY HUNGF 2333 1177 CHPXY 1109 CRBJF HNP 0902 CEO CHPXF
KAMPALA, Sept 6 (Reuters) - Uganda said on Thursday its national oil firm and Chinese offshore oil and gas company CNOOC Ltd had signed an agreement to jointly conduct exploration in a new block in the East African country.
If there's one thing the commodity price crash has taught oil and gas companies, it's capital discipline. The three-year price slump, which saw crude fall to a 13-year low of around $26 per barrel and natural gas prices hitting 17-year lows of around $1.6 per million British thermal units (MMBtu), forced energy executives to consider a new approach to capital deployment.
RDS.B RDS.A RYDBF RDSB RDSA RYDAF CEO
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to CEO / CNOOC Ltd. on message board site Silicon Investor.
as of ET